AstraZeneca is to sell European rights to its cholesterol drug Crestor (rosuvastatin) to Germany’s Grunenthal. Crestor is a statin and at its peak generated annual revenues of more than $7 ...
Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment.
Many adults with high LDL (bad) cholesterol resign themselves to taking a statin drug when no other lifestyle changes will work—and in most cases rightly so, since the evidence is strong for ...
"This breakthrough is a big step forward in developing new malaria treatments," Yu said. "By focusing on PfNCR1, scientists could develop drugs that the parasite finds difficult to develop resistance ...
High Cholesterol Levels at a Young Age Significant ... Common Hair Loss and Prostate Drug May Also Cut Heart Disease Risk in Men and Mice Feb. 20, 2024 — The drug finasteride, also known as ...
This means that Ranbaxy can advance the launch of its generic version of the cholesterol-lowering drug in Australia by 4 months to May 2012 when the patent expires. Ranbaxy is currently fighting a ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...